What challenges could arise in carrying out these strategies and providing care to the patient?

Discussion | Multidimensional Care | Rasmussen College System

Anemia is a condition in which there is a decrease in the number of red blood cells or hemoglobin in the blood, resulting in less oxygen being delivered to the body’s tissues. The three treatment strategies for anemia are blood transfusions, iron supplements, and erythropoietin-stimulating agents (ESAs).

Blood transfusions involve the transfer of blood from a donor to the patient. This is typically done in cases where the patient has lost a significant amount of blood, or their body is unable to produce enough red blood cells on its own. Blood transfusions can provide immediate relief and improve oxygen delivery to the body’s tissues. However, there are potential risks associated with transfusions, such as allergic reactions and transmission of infectious diseases.

Iron supplements are used to treat anemia caused by iron deficiency. Iron is an essential component of hemoglobin, and without sufficient iron, the body cannot produce enough red blood cells. Iron supplements can help to increase the body’s iron stores and improve the production of red blood cells. However, taking too much iron can be harmful and lead to toxicity.

Erythropoietin-stimulating agents (ESAs) are drugs that stimulate the production of red blood cells. ESAs are often used in patients with chronic kidney disease or cancer who have anemia. While ESAs can be effective in increasing red blood cell production, they also have potential risks, including increased risk of blood clots and stroke.

Challenges that could arise in carrying out these treatment strategies include allergic reactions to blood transfusions, difficulty tolerating iron supplements, and potential adverse effects of ESAs. Patients may also have difficulty accessing these treatments due to financial or logistical barriers.

To overcome these challenges, interventions such as premedicating patients with antihistamines before transfusions, using smaller doses of iron supplements and monitoring iron levels regularly, and closely monitoring patients for adverse effects of ESAs can be utilized. Patient education about the importance of following the prescribed treatment regimen and seeking prompt medical attention if any concerning symptoms arise can also help to improve outcomes and reduce potential complications.

Overall, while there are potential challenges associated with treating anemia, there are effective treatment strategies available that can help to improve outcomes and quality of life for patients.